Panomic Biomedical Technology
Suzhou · Founded 2017
About Panomic Biomedical Technology
Suzhou Panomic Biomedical Technology Co., Ltd. (BioNovoGene) was founded in Suzhou Industrial Park Bio-Nano Park in 2013. It is a leading high-tech enterprise focusing on metabolomics in China. Since its establishment, it has established a complete metabolomics detection and analysis platform - PanomicTM / Bionovogene, including metabolite preprocessing platform, high-resolution mass spectrometry analysis platform, and metabolomics data analysis with independent intellectual property rights The system has perfect biomarker discovery capabilities and clinical application capabilities. The company's scientific research team has a rich background, covering biochemistry, bioinformatics, epidemiology and biostatistics, computer science, etc., and has a consultant team composed of top scientists and clinicians.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $29.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2023)
- Website: https://www.panomix.com/
- Phone: +86 0512-62959105
Industries & Categories
Analytics, Bioinformatics, Biotechnology, Health Care, Life Science
Canonical: https://fsome.com/organization/panomic-biomedical-technology-77940 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.